Epidemiological Study In Tuberculosis-Endemic Urban Area in Senegal

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 27, 2018

Primary Completion Date

December 20, 2020

Study Completion Date

July 27, 2022

Conditions
Tuberculosis
Interventions
DIAGNOSTIC_TEST

Quantiferon Gold Plus Test

Small volume of whole blood incubated with specific TB antigen and then dosage of Interferon gamma production.

Trial Locations (1)

BP226

Biomedical Research Center EPLS, Saint-Louis

Sponsors
All Listed Sponsors
collaborator

Biofabri, S.L

INDUSTRY

collaborator

TuBerculosis Vaccine Initiative

OTHER

collaborator

Universidad de Zaragoza

OTHER

collaborator

University of Cape Town

OTHER

collaborator

Institut Pasteur de Madagascar

OTHER

lead

Biomedical Research Center EPLS

OTHER

NCT03767946 - Epidemiological Study In Tuberculosis-Endemic Urban Area in Senegal | Biotech Hunter | Biotech Hunter